연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
1465. Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers.
Kim EK1, Ahn YO, Kim S, Kim TM, Keam B, Heo DS.
Cytotherapy. 2013 Feb;15(2):231-241.e1. doi: 10.1016/j.jcyt.2012.10.019.
Link
1464. Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma.
Kim TM1, Kim S, Ahn YO, Lee SH, Kim DW, Heo DS.
Leuk Lymphoma. 2013 Jul 29. [Epub ahead of print]
Link
1463. Irradiated and activated autologous PBMCs induce expansion of highly cytotoxic human NK cells in vitro.
Ahn YO1, Kim S, Kim TM, Song EY, Park MH, Heo DS.
J Immunother. 2013 Sep;36(7):373-81. doi: 10.1097/CJI.0b013e3182a3430f.
Link
1462. Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer.
Kim JY, Han W1, Moon HG, Ahn SK, Kim J, Lee JW, Kim MK, Kim T, Noh DY.
BMC Cancer. 2013 Oct 27;13:503. doi: 10.1186/1471-2407-13-503.
Link
1461. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
Han SW1, Lee HJ, Bae JM, Cho NY, Lee KH, Kim TY, Oh DY, Im SA, Bang YJ, Jeong SY, Park KJ, Park JG, Kang GH, Kim TY.
Int J Cancer. 2013 May 1;132(9):2209-16. doi: 10.1002/ijc.27888. Epub 2012 Oct 29.
Link
1460. Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy.
Lee DW1, Han SW, Lee HJ, Rhee YY, Bae JM, Cho NY, Lee KH, Kim TY, Oh DY, Im SA, Bang YJ, Jeong SY, Park KJ, Park JG, Kang GH, Kim TY.
Br J Cancer. 2013 May 28;108(10):1978-84. doi: 10.1038/bjc.2013.232. Epub 2013 May 7.
Link
1459. Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing.
Han SW1,?Kim HP,?Shin JY,?Jeong EG,?Lee WC,?Lee KH,?Won JK,?Kim TY,?Oh DY,?Im SA,?Bang YJ,?Jeong SY,?Park KJ,?Park JG,?Kang GH,?Seo JS,?Kim JI,?Kim TY.
PLoS One. 2013 May 21;8(5):e64271. doi: 10.1371/journal.pone.0064271. Print 2013.
Link
1458. Hypoxia reduces endothelial Ang1-induced Tie2 activity in a Tie1-dependent manner.
Yun JH1, Lee HM, Lee EH, Park JW, Cho CH.
Biochem Biophys Res Commun. 2013 Jul 12;436(4):691-7. doi: 10.1016/j.bbrc.2013.06.018. Epub 2013 Jun 14.
Link
1457. Bispecific Her2 × cotinine antibody in combination with cotinine-(histidine)2-iodine for the pre-targeting of Her2-positive breast cancer xenografts.
Yoon S, Kim YH, Kang SH, Kim SK, Lee HK, Kim H, Chung J, Kim IH.
J Cancer Res Clin Oncol. 2014 Feb;140(2):227-33. doi: 10.1007/s00432-013-1548-4. Epub 2013 Dec 1.
Link
1456. Application of bispecific antibody against antigen and hapten for immunodetection and immunopurification.
Kim H, Park S, Lee HK, Chung J.
Exp Mol Med. 2013 Sep 27;45:e43. doi: 10.1038/emm.2013.83.
Link